MEBIAS Discovery Receives Grant from NIDA to Advance Its Signaling-Pathway Selective Mu-Opioid Receptor Drug Candidate Read more
Celltrion Signs ‘Incubation’ Agreement with Emory University for Development of New Drugs for Atherosclerosis Read more
Seattle Genetics Announces ADCETRIS (Brentuximab Vedotin) Approval in Japan for Frontline Hodgkin Lymphoma Read more
Lonza Expands Ibex Solutions to Offer Complete Product Lifecycle Management in One Location Read more
Emergex Enters into MoU with Brazil’s Fiocruz to Develop Novel Vaccines Against Viral Diseases Read more